Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)

NACompletedINTERVENTIONAL
Enrollment

11,976

Participants

Timeline

Start Date

March 23, 2016

Primary Completion Date

April 11, 2019

Study Completion Date

April 11, 2019

Conditions
Premature Birth
Interventions
DRUG

Low dose aspirin

Daily administration of low dose (81 mg) aspirin \[also known as acetylsalicylic acid (ASA\], initiated between 6 0/7 weeks and 13 6/7 weeks GA and continued to 36 0/7 weeks GA compared to an identical appearing placebo. Compliance and outcomes will be assessed biweekly.

DRUG

Placebo

Placebo

Trial Locations (14)

10032

Columbia University, New York

19107

Thomas Jefferson University, Philadelphia

27599

University of North Carolina, Chapel Hill, Chapel Hill

30100

Moi University School of Medicine, Eldoret

35233

University of Alabama, Birmingham, Birmingham

46202

Indiana University, Indianapolis

74800

The Aga Khan University, Karachi

80045

University of Colorado, Denver, Denver

02215

Boston University, Boston

Unknown

Kinshasa School of Public Health, Kinshasa

KLE University's Jawaharlal Nehru Medical College, Belagavi

Lata Medical Research Foundation, Nagpur

University Teaching Hospital, Lusaka

01015

Institute of Nutrition of Central America and Panama (INCAP), Guatemala City

All Listed Sponsors
collaborator

Thomas Jefferson University

OTHER

collaborator

Jawaharlal Nehru Medical College

OTHER

lead

NICHD Global Network for Women's and Children's Health

NETWORK

NCT02409680 - Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN) | Biotech Hunter | Biotech Hunter